PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 209 filers reported holding PDL BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $432,000 | +17.4% | 129,906 | +2.7% | 0.00% | – |
| Q2 2020 | $368,000 | -14.8% | 126,511 | -17.5% | 0.00% | – |
| Q1 2020 | $432,000 | +4.6% | 153,293 | +20.4% | 0.00% | – |
| Q4 2019 | $413,000 | -75.0% | 127,270 | -83.4% | 0.00% | – |
| Q3 2019 | $1,653,000 | +308.1% | 765,069 | +476.2% | 0.00% | – |
| Q2 2019 | $405,000 | -14.6% | 132,775 | +4.1% | 0.00% | – |
| Q1 2019 | $474,000 | -21.8% | 127,518 | -39.0% | 0.00% | – |
| Q4 2018 | $606,000 | -9.4% | 209,183 | -17.7% | 0.00% | – |
| Q3 2018 | $669,000 | +107.1% | 254,196 | +83.9% | 0.00% | – |
| Q2 2018 | $323,000 | -52.7% | 138,240 | -40.5% | 0.00% | – |
| Q1 2018 | $683,000 | -57.1% | 232,216 | -60.1% | 0.00% | – |
| Q4 2017 | $1,593,000 | -37.3% | 581,580 | -22.1% | 0.00% | -100.0% |
| Q3 2017 | $2,539,000 | -16.0% | 746,616 | -39.0% | 0.00% | 0.0% |
| Q2 2017 | $3,022,000 | -24.9% | 1,223,658 | -31.0% | 0.00% | 0.0% |
| Q1 2017 | $4,025,000 | +23.5% | 1,773,425 | +15.4% | 0.00% | 0.0% |
| Q4 2016 | $3,258,000 | +346.3% | 1,536,680 | +605.0% | 0.00% | – |
| Q3 2016 | $730,000 | -3.6% | 217,966 | -9.5% | 0.00% | – |
| Q2 2016 | $757,000 | -1.3% | 240,939 | +4.6% | 0.00% | – |
| Q1 2016 | $767,000 | -0.9% | 230,254 | +5.4% | 0.00% | – |
| Q4 2015 | $774,000 | -48.5% | 218,507 | -26.9% | 0.00% | – |
| Q3 2015 | $1,502,000 | -22.5% | 298,744 | -0.9% | 0.00% | – |
| Q2 2015 | $1,938,000 | -63.8% | 301,461 | -60.4% | 0.00% | -100.0% |
| Q1 2015 | $5,352,000 | -44.5% | 760,773 | -39.2% | 0.00% | -50.0% |
| Q4 2014 | $9,647,000 | +69.1% | 1,251,359 | +63.8% | 0.00% | +100.0% |
| Q3 2014 | $5,706,000 | +97.0% | 763,860 | +155.3% | 0.00% | 0.0% |
| Q2 2014 | $2,896,000 | +287.7% | 299,205 | +233.1% | 0.00% | – |
| Q1 2014 | $747,000 | -90.2% | 89,834 | -90.0% | 0.00% | -100.0% |
| Q4 2013 | $7,607,000 | -12.7% | 901,270 | -17.6% | 0.00% | -33.3% |
| Q3 2013 | $8,714,000 | +7.8% | 1,093,437 | +4.4% | 0.00% | 0.0% |
| Q2 2013 | $8,083,000 | – | 1,046,893 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |